Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hyperfractionation and Accelerated Fractionation in Comparison With Conventional Fractionation in Definitive Radiotherapy of Squamous Cell Carcinoma of Larynx, Oropharynx and Hypopharynx

NCT00291434 is registered in ClinicalTrials.gov with Institute of Radiotherapy and Oncology, Macedonia as lead sponsor.

NCT NCT00291434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00291434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hyperfractionation and Accelerated Fractionation in Comparison With Conventional Fractionation in Definitive Radiotherapy of Squamous Cell Carcinoma of Larynx, Oropharynx and Hypopharynx
Lead sponsor
Institute of Radiotherapy and Oncology, Macedonia
Phase
Observational
Overall status
Completed
Start date
March 31, 1999
Completion date
June 30, 2005
Enrollment
152
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer